Angiogenesis

The discovery of an enzyme that prevents the formation of abnormal blood vessels may enable clinical strategies to manage diabetes-associated blindness.

Uttam Surana shares how SiNOPSEE Therapeutics, the biopharmaceutical startup he co-founded, is developing drugs to block angiogenesis in cancer and degenerative eye conditions.

An imaging technique that distinguishes tumor-associated blood vessels from normal ones could pave the way for better clinical management of tumors.

By interfering with the production and downstream activity of a molecule called Agrin in tumors, scientists can stop the sprouting of blood vessels that promote cancer progression.